Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Glaucoma Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Conventional Glaucoma Surgeries
  • 1.4.3 Minimally Invasive Glaucoma Surgeries
• 1.5 Market by Application
  • 1.5.1 Global Glaucoma Market Share by Application (2014-2025)
  • 1.5.2 Eye Hospitals
  • 1.5.3 Ophthalmology Clinics
  • 1.5.4 Outpatient Surgical Centers
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Glaucoma Market Size
• 2.2 Glaucoma Growth Trends by Regions
  • 2.2.1 Glaucoma Market Size by Regions (2014-2025)
  • 2.2.2 Glaucoma Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Glaucoma Market Size by Manufacturers
  • 3.1.1 Global Glaucoma Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Glaucoma Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Glaucoma Market Concentration Ratio (CR5 and HHI)
• 3.2 Glaucoma Key Players Head office and Area Served
• 3.3 Key Players Glaucoma Product/Solution/Service
• 3.4 Date of Enter into Glaucoma Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Glaucoma Market Size by Type (2014-2019)
• 4.2 Global Glaucoma Market Size by Application (2014-2019)

5 United States

• 5.1 United States Glaucoma Market Size (2014-2019)
• 5.2 Glaucoma Key Players in United States
• 5.3 United States Glaucoma Market Size by Type
• 5.4 United States Glaucoma Market Size by Application

6 Europe

• 6.1 Europe Glaucoma Market Size (2014-2019)
• 6.2 Glaucoma Key Players in Europe
• 6.3 Europe Glaucoma Market Size by Type
• 6.4 Europe Glaucoma Market Size by Application

7 China

• 7.1 China Glaucoma Market Size (2014-2019)
• 7.2 Glaucoma Key Players in China
• 7.3 China Glaucoma Market Size by Type
• 7.4 China Glaucoma Market Size by Application

8 Japan

• 8.1 Japan Glaucoma Market Size (2014-2019)
• 8.2 Glaucoma Key Players in Japan
• 8.3 Japan Glaucoma Market Size by Type
• 8.4 Japan Glaucoma Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Glaucoma Market Size (2014-2019)
• 9.2 Glaucoma Key Players in Southeast Asia
• 9.3 Southeast Asia Glaucoma Market Size by Type
• 9.4 Southeast Asia Glaucoma Market Size by Application

10 India

• 10.1 India Glaucoma Market Size (2014-2019)
• 10.2 Glaucoma Key Players in India
• 10.3 India Glaucoma Market Size by Type
• 10.4 India Glaucoma Market Size by Application

11 Central & South America

• 11.1 Central & South America Glaucoma Market Size (2014-2019)
• 11.2 Glaucoma Key Players in Central & South America
• 11.3 Central & South America Glaucoma Market Size by Type
• 11.4 Central & South America Glaucoma Market Size by Application

12 International Players Profiles

• 12.1 Novartis
  • 12.1.1 Novartis Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Glaucoma Introduction
  • 12.1.4 Novartis Revenue in Glaucoma Business (2014-2019)
  • 12.1.5 Novartis Recent Development
• 12.2 Glaukos
  • 12.2.1 Glaukos Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Glaucoma Introduction
  • 12.2.4 Glaukos Revenue in Glaucoma Business (2014-2019)
  • 12.2.5 Glaukos Recent Development
• 12.3 New World Medical
  • 12.3.1 New World Medical Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Glaucoma Introduction
  • 12.3.4 New World Medical Revenue in Glaucoma Business (2014-2019)
  • 12.3.5 New World Medical Recent Development
• 12.4 Ellex Medical Lasers
  • 12.4.1 Ellex Medical Lasers Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Glaucoma Introduction
  • 12.4.4 Ellex Medical Lasers Revenue in Glaucoma Business (2014-2019)
  • 12.4.5 Ellex Medical Lasers Recent Development
• 12.5 Abbott Laboratories
  • 12.5.1 Abbott Laboratories Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Glaucoma Introduction
  • 12.5.4 Abbott Laboratories Revenue in Glaucoma Business (2014-2019)
  • 12.5.5 Abbott Laboratories Recent Development
• 12.6 Johnson & Johnson
  • 12.6.1 Johnson & Johnson Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Glaucoma Introduction
  • 12.6.4 Johnson & Johnson Revenue in Glaucoma Business (2014-2019)
  • 12.6.5 Johnson & Johnson Recent Development
• 12.7 Bausch Health（BHC）
  • 12.7.1 Bausch Health（BHC） Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Glaucoma Introduction
  • 12.7.4 Bausch Health（BHC） Revenue in Glaucoma Business (2014-2019)
  • 12.7.5 Bausch Health（BHC） Recent Development
• 12.8 Topcon
  • 12.8.1 Topcon Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 Glaucoma Introduction
  • 12.8.4 Topcon Revenue in Glaucoma Business (2014-2019)
  • 12.8.5 Topcon Recent Development
• 12.9 Lumenis
  • 12.9.1 Lumenis Company Details
  • 12.9.2 Company Description and Business Overview
  • 12.9.3 Glaucoma Introduction
  • 12.9.4 Lumenis Revenue in Glaucoma Business (2014-2019)
  • 12.9.5 Lumenis Recent Development
• 12.10 Allergan
  • 12.10.1 Allergan Company Details
  • 12.10.2 Company Description and Business Overview
  • 12.10.3 Glaucoma Introduction
  • 12.10.4 Allergan Revenue in Glaucoma Business (2014-2019)
  • 12.10.5 Allergan Recent Development
• 12.11 Nidek
• 12.12 HAAG-Streit Holding
• 12.13 Essilor International
• 12.14 Hoya
• 12.15 Ziemer Ophthalmic Systems
• 12.16 Carl Zeiss Meditec
• 12.17 Sonomed Escalon
• 12.18 HumanOptics
• 12.19 PhysIOL
• 12.20 Calhoun Vision Center
• 12.21 RISI

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer

Glaucoma is an asymptomatic eye-related disorder that occurs due to the buildup of fluid pressure inside the eye. This leads to damage of the optic nerve in the eye, and is a hereditary disorder. Immediate treatment of people suffering from glaucoma is essential as glaucoma in severe cases may result in loss of vision permanently. In addition, glaucoma is anticipated to be the leading cause of blindness among people in the age group of 60 years and above. The glaucoma surgeries comprise of non-invasive devices, invasive as well as minimally invasive devices to decrease the production of intraocular fluid, which is also known as aqueous humor.
The key factors that drive the market growth include increase in prevalence of glaucoma disease worldwide and growth in geriatric population. In addition, rise in demand for advanced ophthalmic devices supplement the market growth.
In 2018, the global Glaucoma market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Glaucoma status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Glaucoma development in United States, Europe and China.

The key players covered in this study
Novartis
Glaukos
New World Medical
Ellex Medical Lasers
Abbott Laboratories
Johnson & Johnson
Bausch Health（BHC）
Topcon
Lumenis
Allergan
Nidek
HAAG-Streit Holding
Essilor International
Hoya
Ziemer Ophthalmic Systems
Carl Zeiss Meditec
Sonomed Escalon
HumanOptics
PhysIOL
Calhoun Vision Center
RISI

Market segment by Type, the product can be split into
Conventional Glaucoma Surgeries
Minimally Invasive Glaucoma Surgeries

Market segment by Application, split into
Eye Hospitals
Ophthalmology Clinics
Outpatient Surgical Centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Glaucoma status, future forecast, growth opportunity, key market and key players.
To present the Glaucoma development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Glaucoma are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.